We are live on ! Find out more
AKAO

Achaogen Inc
AKAO

Delisted

AKAO was delisted on the 25th of April, 2019.

103 hedge funds and large institutions have $371M invested in Achaogen Inc in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

26% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 27

7% more funds holding

Funds holding: 96103 (+7)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

36% less capital invested

Capital invested by funds: $581M → $371M (-$210M)

67% less call options, than puts

Call options by funds: $1.48M | Put options by funds: $4.51M

Holders
103
Holders Change
+7
Holders Change %
+7.29%
% of All Funds
2.34%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
25
Increased
34
Reduced
27
Closed
18
Calls
$1.48M
Puts
$4.51M
Net Calls
-$3.02M
Net Calls Change
-$628K
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$56M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$54M -$440K -35,095 -0.7%
BlackRock
3
BlackRock
New York
$30.5M +$7.91M +630,547 +29%
State Street
4
State Street
Massachusetts
$25.6M +$5.32M +423,785 +22%
FCMI
5
Foresite Capital Management III
California
$25.5M +$5.81M +462,894 +24%
PC
6
Polar Capital
United Kingdom
$20.2M -$265K -21,078 -1%
Vanguard Group
7
Vanguard Group
Pennsylvania
$16.6M +$187K +14,877 +1%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$16.1M -$9.46M -753,499 -33%
TCM
9
TimesSquare Capital Management
New York
$14.7M +$79.1K +6,300 +0.5%
VVM
10
Versant Venture Management
California
$13.8M
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$10.2M +$103K +8,180 +0.9%
Renaissance Technologies
12
Renaissance Technologies
New York
$6.9M +$7.83M +623,900 +3,319%
PM
13
Prosight Management
Texas
$6.13M +$7.17M +570,920 New
Deutsche Bank
14
Deutsche Bank
Germany
$5.55M +$4.9M +390,241 +307%
Axa
15
Axa
France
$4.76M +$4.55M +362,337 +450%
Northern Trust
16
Northern Trust
Illinois
$4.04M -$63.5K -5,057 -1%
FMBTD
17
First Midwest Bank Trust Division
Illinois
$4.02M +$4.12M +327,971 +712%
Lord, Abbett & Co
18
Lord, Abbett & Co
New Jersey
$3.93M -$574K -45,745 -11%
Goldman Sachs
19
Goldman Sachs
New York
$3.56M +$116K +9,267 +3%
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$3.22M +$3.77M +300,000 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$3.17M +$13.9K +1,106 +0.4%
AG
22
Artal Group
Luxembourg
$2.69M
Morgan Stanley
23
Morgan Stanley
New York
$2.43M +$552K +43,959 +24%
IBT
24
International Biotechnology Trust
United Kingdom
$2.2M +$1.63M +130,000 +174%
Fiera Capital (Canada)
25
Fiera Capital (Canada)
Quebec, Canada
$1.95M -$540K -43,047 -19%

AKAO Hedge Fund Activity: Q4 2017 in Review

103 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Achaogen Inc (AKAO) for Q4 2017, worth a combined $371M — down 36% from $581M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new AKAO positions and 18 closed out — a net gain of 7 holders — while 34 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $7.91M. The largest seller was Baker Bros. Advisors, cutting an estimated $47.2M.

  • 103 institutional investors held Achaogen Inc (AKAO) as of Q4 2017, up from 96 in Q3 2017.
  • Funds reported $371M of Achaogen Inc stock for Q4 2017, down 36% quarter-over-quarter.
  • 25 funds opened new Achaogen Inc positions in Q4 2017 and 18 closed out, a net change of +7 holders.
  • The largest Achaogen Inc buyer in Q4 2017 was BlackRock, an estimated $7.91M added.
  • The largest Achaogen Inc seller in Q4 2017 was Baker Bros. Advisors, an estimated $47.2M sold.

Based on aggregated 13F filings for Q4 2017.